Protein Folding and Stability, Macromolecular Interactions, and Ligand Binding
Protein Folding and Stability, Macromolecular Interactions, and Ligand Binding
批准号:
7594358
负责人:
Grzegorz Piszczek
金额:
$92.12万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ATP phosphohydrolaseAcidsActin-Binding ProteinActinsAntioxidantsBindingBiologicalBiological AssayBuffersC-terminalCalorimetryCell physiologyCharacteristicsComplexConditionCysteineDependenceDissociationEndopeptidasesEnzymesEquilibriumEscherichia coliExcisionFamilyFilamentGoalsHumanInvestigationIonic StrengthsLigand BindingLiteratureMeasurementMethodsMicrofilamentsMolecularMolecular ChaperonesMusNucleotidesOxidation-ReductionPathway interactionsPeptide HydrolasesPeptidesPhosphorylationPlayPlus End of the Actin FilamentPoint MutationProcessProteinsRNA Cap-Binding ProteinsRangeRegulationReportingRoleShapesSignal PathwaySignal TransductionStructure-Activity RelationshipSystemTitrationsWalkersanaloganalytical ultracentrifugationcrosslinkdimerinsightmonomermutantoxidationperoxiredoxin Ipolymerizationpolypeptideprotein foldingresearch studysedimentation coefficientsedimentation velocitytoolunfoldase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Conformational dynamics of the ClpA and ClpP oligomers. (GP, AG, MRM)
ClpA, a Hsp100/Clp chaperone from E. Coli, forms a hexameric ring of subunits that unfolds native proteins in an ATP-dependent process and delivers the unfolded polypeptides to ClpP protease for degradation. The precise mechanism of ATP driven unfoldase activity of ClpA and pathway for substrate fragments discharge from the ClpAP complexes are important but still not well understood problems. To gain insight into those processes we have used sedimentation velocity measurements to determine overall conformational changes of the ClpA hexamer upon peptide binding and in different nucleotide states. The ClpP tetradecamer stability and ClpAP complexes have also been studied by the same method. Previous calorimetric titrations of ClpA hexamer with SsrA target peptide have suggested that peptide binding may trigger conformational changes within the ClpA hexamer. This observations were confirmed by analytical ultracentrifugation studies indicating that ClpA hexamer conformational changes induced by SsrA peptide binding are reflected by sedimentation coefficient distributions.
ClpA has two ATP binding domains (D1 and D2) and both the enzyme oligomerization and unfoldase activity is nucleotide dependent. In previous experiments ATPgS, the nonhydrolyzable ATP analog have been used. To study conformational changes of ClpA in different nucleotide states single point mutations in ClpA nucleotide binding Walker-B motifs of domains D1 and D2 were introduced. The double D1/D2 ClpA mutant forms stable hexamers in the presence of ATP, as confirmed by analytical ultracentrifugation, but has no detectable ATPase activity.
The oligomerization studies of ClpP protease form E. Coli indicate that ClpP tetradecamers disassemble at very low protein concentration, which may facilitate removal of degradation fragments from the ClpP proteolytic chamber and may also play a role in macromolecular dynamics of ClpAP complexes. To study the importance of this process a crosslinked cysteine mutant of ClpP was used. As confirmed by analytical ultracentrifugation, crosslinked ClpP maintains the tetradecamer form even at extremely low protein concentrations. This ClpP mutant will provide an important tool to study the dynamics of ClpAP complexes.
Oxidation dependent oligomerization of the human Peroxiredoxin I (hPrxI). (GP, AG, DYL, SGR)
Human Peroxiredoxin I belongs to a large and diverse family of antioxidant enzymes that also regulate cell signaling pathways, apoptosis and differentiation. Peroxiredoxins (Prxs) can be regulated by changes to phosphorylation and redox state and oligomerization is believed to play a key role in this regulation. Most of 2-Cys Prxs demonstrate large changes in their oligomeric state, forming either dimers or decamers with the characteristic doughnut shape. Prxs oligomerization is promoted by their oxidation state but also by other factors, such as ionic strength and pH.
Oligomerization of human Prx I was studied by analytical ultracentrifugation. Since hPrx I can be reversibly hyperoxidized to cysteinesulfinic acid (SO2H), both reduced, oxidized and hyperoxidized forms of this enzyme were characterized using large range of protein concentrations and different buffer conditions. Sedimentation velocity experiment show that hPrxI redox-dependent oligomerization is strikingly different from other Prxs, reported in the literature. The oxidized hPrxI is an obligate homodimer and the reduced form of this enzyme is in a concentration dependent monomer-dimer-decamer equilibrium. The hyperoxidized form of hPrxI also forms decamers, and the concentration dependence of this process in higher than that of the reduced form of the enzyme. The pH and ionic strength dependence of hPrxI oligomerization was studied in a range of buffer conditions. Interaction of different forms of hPrxI with human Sulfiredoxin (hSrx) was also examined.
Capping Protein - CARMIL Interaction Studies. (GP, AG, TU, JAH)
Capping Protein (CP) is a highly conserved actin-binding protein that is essential for normal actin dynamics. CP binds to the barbed end of the actin filament blocking both association and dissociation of actin monomers. One potential regulator of CP is CARMIL, that might act as potent CP antagonist and inhibit CP interaction with actin filaments.
Two regions on of the CARMIL protein (CAH3-a and CAH3-b) were identified as crucial for interactions with CP. Cloned fragments of CARMIL with sequences encompassing both the CAH3-a and CAH3-b regions, with several single point mutations with either of them, were used to study CARMIL interaction with mouse Capping Protein (mCP) heterodimer (a, b) by Isothermal Titration Calorimetry (ITC). Results obtained by ITC were compared with those from an actin polymerization inhibition assay.
The C-terminals of CP a and b subunits form tentacles that can make extensive contacts with actin when CP binds to the barbed end of the filament. The mCP deletion mutant lacking the tentacle on the a subunit (mCPa1D) is unable to make tight complexes with actin. Since CARMIL may potentially regulate capping by interactions with C-terminals of mCP a and b subunits, both mCPa1D and mCPb2D (lacking the tentacle on the b subunit) were used to study their interactions with several CARMIL CAH3 mutants by ITC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biophysics Core Facility
-
批准号:9553334
-
项目类别:
-
资助金额:$50.56万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:10023088
-
项目类别:
-
资助金额:$63.01万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Facility
-
批准号:7970124
-
项目类别:
-
资助金额:$28.19万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:10699762
-
项目类别:
-
资助金额:$87.03万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Facility
-
批准号:8149701
-
项目类别:
-
资助金额:$31.27万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Substrate Peptide Interactions with the E. Coli ClpA Hex
-
批准号:6675579
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Facility
-
批准号:8344977
-
项目类别:
-
资助金额:$38.29万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:8746868
-
项目类别:
-
资助金额:$37.16万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Protein Folding and Stability, Macromolecular Interactio
-
批准号:7321501
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:10929227
-
项目类别:
-
资助金额:$101.39万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:8558129
-
项目类别:
-
资助金额:$34.25万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:8940151
-
项目类别:
-
资助金额:$2.52万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Calorimetric and fluorescence studies of protein propert
-
批准号:7154192
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:10495101
-
项目类别:
-
资助金额:$61.29万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:10265888
-
项目类别:
-
资助金额:$58.17万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Protein Folding and Stability, Macromolecular Interactions, and Ligand Binding
-
批准号:7734937
-
项目类别:
-
资助金额:$33.9万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Calorimetric and fluorescence studies of protein propert
-
批准号:6966857
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Calorimetric and fluorescence studies of protein propert
-
批准号:6815656
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
Biophysics Core Facility
-
批准号:9362241
-
项目类别:
-
资助金额:$123.83万
-
财政年份:--
-
负责人:Grzegorz Piszczek
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: